ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis
Background. The beta-2 adrenergic receptor (ADRB2) Arg16Gly polymorphism may alter the bronchodilation response to long-acting beta2-agonists, thereby influencing the clinical effectiveness of LABAs plus corticosteroids (ICS) treatment. But the results of individual studies are inconclusive. Methods...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/5712805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524562132467712 |
|---|---|
| author | Xi Wang Qian Li Ruming Liu Jin He Di Wu Yun Wang Jun Zhang |
| author_facet | Xi Wang Qian Li Ruming Liu Jin He Di Wu Yun Wang Jun Zhang |
| author_sort | Xi Wang |
| collection | DOAJ |
| description | Background. The beta-2 adrenergic receptor (ADRB2) Arg16Gly polymorphism may alter the bronchodilation response to long-acting beta2-agonists, thereby influencing the clinical effectiveness of LABAs plus corticosteroids (ICS) treatment. But the results of individual studies are inconclusive. Methods. A systematic search was conducted in PubMed, Embase, the Cochrane Database, WHO International Clinical Trials Registry Platform, Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical Literature Database, and VIP databases. The meta-analysis was performed with RevMan statistical software (version 5.2), and potential publication bias was estimated by Egger’s test using STATA (version 12.0), with p<0.05 indicating significant publication bias. Results. We found 5 cohort studies with a total of 632 patients and included them in the meta-analysis. There are no significant differences in pulmonary function response between patients with the Arg/Arg and Arg/Gly phenotype (SMD −0.04, 95% CI −0.45 to 0.37; p=0.84). There were also no significant differences in the pulmonary function response between patients with the Arg/Arg and Gly/Gly phenotype (MD −0.03, 95% CI −0.07 to 0.02; p=0.28). Conclusions. Our systematic review and meta-analysis suggest that ADRB2 Arg16Gly polymorphism is not associated with pulmonary response to asthma treatment with ICS plus LABAs. |
| format | Article |
| id | doaj-art-a30fdfbd32294e21997f9b4f65bd03f8 |
| institution | Kabale University |
| issn | 1198-2241 1916-7245 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-a30fdfbd32294e21997f9b4f65bd03f82025-02-03T05:52:51ZengWileyCanadian Respiratory Journal1198-22411916-72452018-01-01201810.1155/2018/57128055712805ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-AnalysisXi Wang0Qian Li1Ruming Liu2Jin He3Di Wu4Yun Wang5Jun Zhang6The Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaThe Department of Clinical Pharmacy, The First Affiliated Hospital of Kunming Medical University, Kunming, ChinaBackground. The beta-2 adrenergic receptor (ADRB2) Arg16Gly polymorphism may alter the bronchodilation response to long-acting beta2-agonists, thereby influencing the clinical effectiveness of LABAs plus corticosteroids (ICS) treatment. But the results of individual studies are inconclusive. Methods. A systematic search was conducted in PubMed, Embase, the Cochrane Database, WHO International Clinical Trials Registry Platform, Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical Literature Database, and VIP databases. The meta-analysis was performed with RevMan statistical software (version 5.2), and potential publication bias was estimated by Egger’s test using STATA (version 12.0), with p<0.05 indicating significant publication bias. Results. We found 5 cohort studies with a total of 632 patients and included them in the meta-analysis. There are no significant differences in pulmonary function response between patients with the Arg/Arg and Arg/Gly phenotype (SMD −0.04, 95% CI −0.45 to 0.37; p=0.84). There were also no significant differences in the pulmonary function response between patients with the Arg/Arg and Gly/Gly phenotype (MD −0.03, 95% CI −0.07 to 0.02; p=0.28). Conclusions. Our systematic review and meta-analysis suggest that ADRB2 Arg16Gly polymorphism is not associated with pulmonary response to asthma treatment with ICS plus LABAs.http://dx.doi.org/10.1155/2018/5712805 |
| spellingShingle | Xi Wang Qian Li Ruming Liu Jin He Di Wu Yun Wang Jun Zhang ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis Canadian Respiratory Journal |
| title | ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis |
| title_full | ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis |
| title_fullStr | ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis |
| title_short | ADRB2 Arg16Gly Polymorphism and Pulmonary Function Response of Inhaled Corticosteroids plus Long-Acting Beta Agonists for Asthma Treatment: A Systematic Review and Meta-Analysis |
| title_sort | adrb2 arg16gly polymorphism and pulmonary function response of inhaled corticosteroids plus long acting beta agonists for asthma treatment a systematic review and meta analysis |
| url | http://dx.doi.org/10.1155/2018/5712805 |
| work_keys_str_mv | AT xiwang adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT qianli adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT rumingliu adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT jinhe adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT diwu adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT yunwang adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis AT junzhang adrb2arg16glypolymorphismandpulmonaryfunctionresponseofinhaledcorticosteroidspluslongactingbetaagonistsforasthmatreatmentasystematicreviewandmetaanalysis |